Armen Aprikian
Professor, Department of Surgery (Division of Urology)
Director, Cancer Care Mission;
Head, Department of Oncology McGill University Health Centre
![Armen Aprikian Armen Aprikian](https://www.mcgill.ca/urology/files/urology/styles/medium_focal__220_x_220_/public/armen_aprikian.jpg?itok=wkWFF_3g)
- Familial and genetic prostate cancer
- Neuroendocrine differentiation and neuropeptide-induced progression of prostate cancer
- Patters of care in urologic oncology surgery
- Biological markers of prognosis in prostate cancer
Urologic Oncology
Dr. Armen Aprikian graduated from the University of Sherbrooke Medical School in Quebec in 1985 and completed his urology residency training at McGill University in 1990. He then pursued a 3-year research and clinical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Centre in New York City. In 1993 he was appointed Assistant Professor of Surgery (Urology) at McGill University and began his career in prostate and bladder cancer research and as a clinical urologic oncologist. In 1998 he became the McGill Division of Urology Training Program Director and in 2001 established the Annual Canadian Senior Resident Urologic Oncology Course which runs to this day. In 2004, he became the Head of the Division of Urology at McGill University and in 2007 became full professor of surgery. Finally, in 2009 he was appointed the Medical Director of the McGill University Health Centre Cancer Care Mission and Department of Oncology.
Dr. Aprikian has been awarded the American Society of Clinical Oncology Young Investigator Award, the American Urologic Association Practising Urologist Award, the Canadian Urology Association Scholarship, the McGill University William Dawson Scholar Career Award and the FRSQ Clinician Scientist Award for 12 years. He has obtained independent peer-reviewed grants from several organizations including the US Department of Defense. In 2004, he was a founding member of Procure, a Quebec-based Prostate Cancer Foundation dedicated to research and public awareness. Most recently, he has initiated a prospective longitudinal comprehensive biobank project for prostate cancer across the entire province of Quebec. He is actively involved in a leadership role in provincial guidelines in cancer surgery outcomes and standards of care. Finally, in 2010 he was appointed the Richard Tomlinson Chair in Prostate Cancer at McGill University.